Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
A private biopharmaceutical company .
Leal Therapeutics develops novel therapeutics for patients.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
Belenos Biosciences is a company.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Turnstone Biologics is a privately-held clinical stage biotech company.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Erasca is a developer of oncology drugs intended to provide precision oncology options.
Renasant Bio is a biopharmaceutical company pioneering disease-modifying oral small molecule treatments.
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Erasca received $632.5M in a Post-IPO Equity round. OrbiMed's total known invested capital is $28.8B.
OrbiMed's average investment size is $134.0M across its portfolio of 289 companies.
Recent OrbiMed portfolio additions include ReCode Therapeutics, Synlogic, ACELYRIN, XinThera, Neurogastrx. These companies were founded in 2020 or later.